(Q37399996)

English

Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

scientific article published on 24 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

acute decompensated heart failure

1 reference

based on heuristic

inferred from title

Mihai Gheorghiade

10

object named as

Mihai Gheorghiade

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

2

object named as

Marco Metra

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Gerasimos Filippatos

6

object named as

Gerasimos S Filippatos

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

7

object named as

Hani N Sabbah

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Matthew E. Harinstein

5

object named as

Matthew E Harinstein

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Hashim Khan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

John E A Blair

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Mark Vogel

4

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Herve Porchet

8

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Giovanni Valentini

9

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

24 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Heart Failure Reviews

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

277-287

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

https://scigraph.springernature.com/pub.10.1007/s10741-009-9136-z

0 references

Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS10741-009-9136-Z

21 January 2018

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute heart failure syndromes: current state and framework for future research

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium cycling and signaling in cardiac myocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Istaroxime: a new luso-inotropic agent for heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19238540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10741-009-9136-Z

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37399996&oldid=2101622208"